This study found that serum ESPL1 levels in patients with chronic HBV infection showed a trend from quantitative to qualitative changes consistent with the development of disease progression.
← all excerpts
Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
1
—
—